BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34974572)

  • 1. Serum p53 antibodies detection in oral squamous cell carcinoma, oral potentially malignant disorders and healthy individuals: A multicentre study.
    Khan AS; Ahmad S; Ullah Z; Haq M; Farooq MU; Khan M
    J Pak Med Assoc; 2021 Oct; 71(10):2364-2368. PubMed ID: 34974572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
    Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
    Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of tissue p53 protein expression and serum p53 antibodies in oral potentially malignant disorders: Relative to oral squamous cell carcinoma.
    Khan AS; Ahmad S; Ullah Z; Sadiq N; Haq M; Sheikh AK
    J Taibah Univ Med Sci; 2022 Jun; 17(3):415-423. PubMed ID: 35722241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis.
    Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H
    Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study).
    Abdelwhab A; Shaker O; Aggour RL
    Oral Dis; 2023 May; 29(4):1487-1494. PubMed ID: 35080082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CK19 and VEGF gene expression, ki67 antigen, p53 protein, C-erb-B2, and their relationship in oral squamous cell carcinoma.
    Shen Y; Xu Z; Liu M; Piao S; Li J
    Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):233-239. PubMed ID: 35818248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
    Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
    Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
    Khan S; Alamgir MM
    J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of serum p53 antibody as a biomarker in oral and pharyngeal squamous cell carcinoma.
    Hirokawa S; Araki K; Yamashita T; Uno K; Tomifuji M; Shimada H; Shiotani A
    Acta Otolaryngol; 2023 Jan; 143(1):85-90. PubMed ID: 36694958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus guidelines on management of oral potentially malignant disorders.
    Birur PN; Patrick S; Warnakulasuriya S; Gurushanth K; Raghavan SA; Rath GK; Chaturvedi P; Chandru V; Mathew B; Prabhash K; Gurudath S; Mukhia N; Sunny SP; Mehrotra R; Vivek V; Patil S; Kumar GS; Fasalkar S; Pratima R; Kuriakose MA
    Indian J Cancer; 2022; 59(3):442-453. PubMed ID: 36412324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic potential of CK-19 managing disseminated oral squamous cell carcinomas in Pakistan: A descriptive cross-sectional study.
    Iqbal W; Tariq U; Surwaich A; Channa SA; Majid A; Ali S; Bukhari N
    J Pak Med Assoc; 2021 Mar; 71(3):1028-1032. PubMed ID: 34057972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair, NFKβ, and TP53 polymorphisms associated with potentially malignant disorders and oral squamous cell carcinoma in Argentine patients.
    Galíndez MF; Carrica A; Zarate AM; Secchi D; Don J; Barra JL; Brunotto M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Mar; 131(3):339-346. PubMed ID: 33309268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma].
    Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544
    [No Abstract]   [Full Text] [Related]  

  • 15. First comprehensive report on distribution of histologically confirmed oral and maxillofacial pathologies; a nine-year retrospective study.
    Shabir H; Irshad M; Durrani SH; Sarfaraz A; Arbab KN; Khattak MT
    J Pak Med Assoc; 2022 Apr; 72(4):685-690. PubMed ID: 35614602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence spectroscopy for the detection of potentially malignant disorders and squamous cell carcinoma of the oral cavity.
    Francisco AL; Correr WR; Azevedo LH; Kern VG; Pinto CA; Kowalski LP; Kurachi C
    Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):82-90. PubMed ID: 24704941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
    Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
    Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inhibitor of apoptosis family proteins in human oral squamous cell carcinogenesis.
    Chen YK; Huse SS; Lin LM
    Head Neck; 2011 Jul; 33(7):985-98. PubMed ID: 20967871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
    Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
    Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.